Diana Blithe, PhD, Program Director, Contraception and Reproductive Health Branch of NIH/NICHD. Conducting trials of CDB-2914. Areas of expertise: Research on male and female contraceptive methods, clinical trials, endocrinology, new post-coital methods, mechanism of action. USA.

Francine Coeytaux, MPH, co-founder of the Pacific Institute for Women’s Health and founding board member of the Reproductive Health Technologies Project, directed the Compton Foundation’s Emergency Contraception Initiative.  She currently serves on the Boards of the Concept Foundation, EngenderHealth and Women’s Dignity.  Areas of expertise: founding member of EC Consortium, new reproductive technologies including EC and medical abortion, familiarity with funding mechanisms and opportunities, knowledgeable about advocacy issues. USA.

Daniel Davis, MD, MPH, medical reviewer in the Division of Reproductive and Urologic Products at the Food and Drug Administration (FDA) since 1997.  Areas of expertise: clinical trial design, microbicide and spermicide development, different delivery systems (oral, transdermal, vaginal, implants, intrauterine, intramuscular) for hormonal and non-hormonal contraception, emergency contraception, and medical abortion. Board certified in obstetrics and gynecology. USA.

Anibal Faundes, Professor of Obstetrics and gynecology, University of Campinas (Retired, working as volunteer).  Senior Investigator, Center for Research in Reproductive Health (Cemicamp). Chair, Working Group on Prevention of Unsafe Abortion of FIGO. Areas of expertise: Abortion, contraception, reproductive physiology. Brazil.

Ian Fraser, MD, Professor in Reproductive Medicine at the University of Sydney. Honorary Secretary of FIGO. Member of ICCR. Areas of expertise: Contraception, menstrual disorders, endometriosis, clinical literature on EC. Australia.

Helena von Hertzen, MD, DDS. Senior Consultant for the Concept Foundation.  Former Manager of the WHO Task Force on Post-ovulatory Methods for Fertility Regulation organizing many large multinational clinical trials for WHO, including LNG and mifepristone trials for EC. Areas of expertise: clinical trials of LNG and mifepristone. Switzerland.

Pramilla Senanayake, former Assistant Director General of the International Planned Parenthood Federation in London and immediate past Chair of the Foundation Council of the Geneva-based Global Forum for Health Research. Board Chair of Concept Foundation. Founding member of ICEC. Areas of expertise: service delivery, organizational management. Sri Lanka.

Jeff Spieler, currently Senior Technical Advisor for Science and Technology in Population and Reproductive Health.  Formerly Chief of the Research, Technology and Utilization Division, Office of Population and Reproductive Health, Bureau of Global Health, USAID. He retired from USAID after 26 years of service in October 2008, and returned to USAID full-time under a contract to assume his current position.   He spent 11 years in WHO's Human Reproduction Programme before joining USAID. Formerly served on ICEC’s Products Committee. Areas of expertise include contraceptive and HIV prevention technologies, the intersection between technology and family planning service delivery, and developing and managing public-private partnerships. USA.

James Trussell, PhD, Director of the Office of Population Research at Princeton University, demographer, founded Not-2-late.com and has authored major publications on EC. Areas of expertise: contraceptive effectiveness, statistics. USA.

Paul Van Look, MD PhD FRCOG was Director of the Department of Reproductive Health and Research at the World Health Organization from 1998 until early 2009 and is currently an independent consultant in sexual and reproductive health.  He has been the recipient of several honorary degrees and titles and was awarded the 2008 Allan Rosenfield Award for Lifetime Contributions to International Family Planning. Areas of expertise: family planning, abortion, infertility, management of international sexual and reproductive health organization. Switzerland.